Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OmniScience Pharmaceuticals Inc.

www.omnipharm.com

Latest From OmniScience Pharmaceuticals Inc.

Omniscience Pharmaceuticals Inc.

A carefully integrated array of genomics, bioinformatics, and advanced cloning methods to identify and control metabolic pathways of microorganisms is the driver behind Omniscience Pharmaceuticals Inc.'s strategy for disovering new antibiotics.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Biotechnology
    • Drug Discovery Tools
    • Drug Discovery Tools
      • Molecular Diversity
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • OmniScience Pharmaceuticals Inc.
  • Senior Management
  • Michael G Chaparian, PhD, Pres. & CSO
    Duncan Hill, VP, Bus. Dev.
  • Contact Info
  • OmniScience Pharmaceuticals Inc.
    Phone: (480) 456-0145
    4665 S. Ash Ave. Suite G-18
    Tempe, AZ 85252
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register